Literature DB >> 17719230

Interaction of ASK1 and the beta-amyloid precursor protein in a stress-signaling complex.

Veronica Galvan1, Surita Banwait, Patricia Spilman, Olivia F Gorostiza, Alyson Peel, Marina Ataie, Danielle Crippen, Wei Huang, Gurleen Sidhu, Hidenori Ichijo, Dale E Bredesen.   

Abstract

The amyloid precursor protein (APP) is a type I transmembrane protein translocated to neuronal terminals, whose function is still unknown. The C-terminus of APP mediates its interaction with cellular adaptor and signaling proteins, some of which signal to the stress-activated protein kinase (SAPK) pathway. Here we show that ASK1, a MAPKKK that activates two SAPKs, c-Jun N-terminal-kinase (JNK) and p38, is present in a complex containing APP, phospho-MKK6, JIP1 and JNK1. In primary neurons deprived of growth factors, as well as in brains of (FAD)APP-transgenic mice, ASK1 was upregulated in neuronal projections, where it interacted with APP. In non-transgenic brains, ASK1 and APP associated mainly in the ER. Our results indicate that recruitment of ASK1 to stress-signaling complexes assembled with APP may be triggered and enhanced by cellular stress. Thus, ASK1 may be the apical MAPKKK in a signaling complex assembled with APP as a response to stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719230      PMCID: PMC2084074          DOI: 10.1016/j.nbd.2007.06.017

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  76 in total

1.  The intracellular cytoplasmic domain of the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine-binding domain proteins in the yeast two-hybrid system.

Authors:  D M McLoughlin; C C Miller
Journal:  FEBS Lett       Date:  1996-11-18       Impact factor: 4.124

2.  A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth.

Authors:  D H Small; V Nurcombe; G Reed; H Clarris; R Moir; K Beyreuther; C L Masters
Journal:  J Neurosci       Date:  1994-04       Impact factor: 6.167

Review 3.  Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives.

Authors:  M P Mattson
Journal:  Physiol Rev       Date:  1997-10       Impact factor: 37.312

4.  Trafficking of cell-surface beta-amyloid precursor protein: evidence that a sorting intermediate participates in synaptic vesicle recycling.

Authors:  N R Marquez-Sterling; A C Lo; S S Sisodia; E H Koo
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

5.  Amyloid precursor protein is enriched in axolemma and periaxolemmal-myelin and associated clathrin-coated vesicles.

Authors:  V S Sapirstein; R Durrie; M J Berg; N Marks
Journal:  J Neurosci Res       Date:  1994-02-15       Impact factor: 4.164

6.  Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein.

Authors:  M P Mattson; B Cheng; A R Culwell; F S Esch; I Lieberburg; R E Rydel
Journal:  Neuron       Date:  1993-02       Impact factor: 17.173

7.  Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system.

Authors:  S S Sisodia; E H Koo; P N Hoffman; G Perry; D L Price
Journal:  J Neurosci       Date:  1993-07       Impact factor: 6.167

8.  Association and release of the amyloid protein precursor of Alzheimer's disease from chick brain extracellular matrix.

Authors:  D H Small; V Nurcombe; R Moir; S Michaelson; D Monard; K Beyreuther; C L Masters
Journal:  J Neurosci       Date:  1992-11       Impact factor: 6.167

9.  Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein.

Authors:  K Furukawa; S W Barger; E M Blalock; M P Mattson
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962

10.  The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein.

Authors:  F Fiore; N Zambrano; G Minopoli; V Donini; A Duilio; T Russo
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

View more
  9 in total

1.  Reversal of learning deficits in hAPP transgenic mice carrying a mutation at Asp664: a role for early experience.

Authors:  Junli Zhang; Olivia F Gorostiza; Huidong Tang; Dale E Bredesen; Veronica Galvan
Journal:  Behav Brain Res       Date:  2009-09-12       Impact factor: 3.332

Review 2.  Nanoparticles in the brain: a potential therapeutic system targeted to an early defect observed in many neurodegenerative diseases.

Authors:  Shermali Gunawardena
Journal:  Pharm Res       Date:  2013-04-27       Impact factor: 4.200

Review 3.  Pathological role of apoptosis signal-regulating kinase 1 in human diseases and its potential as a therapeutic target for cognitive disorders.

Authors:  So Yeong Cheon; Kyoung Joo Cho
Journal:  J Mol Med (Berl)       Date:  2019-01-07       Impact factor: 4.599

4.  Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664.

Authors:  Veronica Galvan; Junli Zhang; Olivia F Gorostiza; Surita Banwait; Wei Huang; Marina Ataie; Huidong Tang; Dale E Bredesen
Journal:  Behav Brain Res       Date:  2008-04-08       Impact factor: 3.332

5.  Development of an HTS-compatible assay for the discovery of ASK1 signalosome inhibitors using alphascreen technology.

Authors:  Emmanuel Sturchler; Weimin Chen; Timothy Spicer; Peter Hodder; Patricia McDonald; Derek Duckett
Journal:  Assay Drug Dev Technol       Date:  2014-05       Impact factor: 1.738

Review 6.  Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic target for Alzheimer's disease.

Authors:  Juhyun Song; Kyung Ah Park; Won Taek Lee; Jong Eun Lee
Journal:  Int J Mol Sci       Date:  2014-01-29       Impact factor: 5.923

Review 7.  EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease.

Authors:  Vladimir Khavinson; Natalia Linkova; Ekaterina Kozhevnikova; Svetlana Trofimova
Journal:  Molecules       Date:  2020-12-31       Impact factor: 4.411

8.  Cross-Talking Pathways of Forkhead Box O1 (FOXO1) Are Involved in the Pathogenesis of Alzheimer's Disease and Huntington's Disease.

Authors:  Liyang Liu; Jun Bai; Fangxi Liu; Ying Xu; Mei Zhao; Chuansheng Zhao; Zhike Zhou
Journal:  Oxid Med Cell Longev       Date:  2022-02-03       Impact factor: 6.543

Review 9.  Therapeutic targets in the ASK1-dependent stress signaling pathways.

Authors:  Ryoichi Hayakawa; Teruyuki Hayakawa; Kohsuke Takeda; Hidenori Ichijo
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.